CNR Institutional Research Information System

CUTRUPI, SEBASTIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.451
NA - Nord America 688
EU - Europa 348
SA - Sud America 343
AF - Africa 33
OC - Oceania 5
Totale 2.868
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 689
US - Stati Uniti d'America 651
CN - Cina 281
BR - Brasile 280
HK - Hong Kong 178
IT - Italia 125
VN - Vietnam 123
FR - Francia 104
BD - Bangladesh 46
KR - Corea 36
DE - Germania 23
GB - Regno Unito 22
IN - India 22
AR - Argentina 21
CA - Canada 19
NL - Olanda 19
JP - Giappone 16
ID - Indonesia 14
EC - Ecuador 13
FI - Finlandia 10
MX - Messico 9
ZA - Sudafrica 9
VE - Venezuela 8
MA - Marocco 7
PE - Perù 7
PL - Polonia 6
CO - Colombia 5
IE - Irlanda 5
RU - Federazione Russa 5
SA - Arabia Saudita 5
TR - Turchia 5
UY - Uruguay 5
IL - Israele 4
IQ - Iraq 4
PH - Filippine 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
NP - Nepal 3
PK - Pakistan 3
SE - Svezia 3
AO - Angola 2
AU - Australia 2
BE - Belgio 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
PW - Palau 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
TW - Taiwan 1
Totale 2.868
Salva come PNG Salva come JPEG
Città #
Singapore 434
Santa Clara 244
Hong Kong 177
Hefei 91
Lauterbourg 88
San Jose 64
Beijing 54
Ashburn 53
Ho Chi Minh City 44
Seoul 36
Los Angeles 29
Hanoi 27
New York 21
São Paulo 20
Milan 16
Dallas 15
Buffalo 11
Frankfurt am Main 11
Tokyo 10
Da Nang 8
Rio de Janeiro 8
Rome 8
Belo Horizonte 7
Toronto 7
Catania 6
Helsinki 6
Bauru 5
Biên Hòa 5
Brasília 5
Düsseldorf 5
Guayaquil 5
Jakarta 5
Quito 5
Warsaw 5
Baghdad 4
Belém 4
Curitiba 4
Dublin 4
Haiphong 4
Montevideo 4
Santo André 4
Amsterdam 3
Atlanta 3
Boston 3
Cape Town 3
Chennai 3
Dhaka 3
Greensboro 3
Houston 3
Hải Dương 3
Johannesburg 3
Juiz de Fora 3
Kathmandu 3
Lappeenranta 3
Lima 3
Magé 3
Minamishinagawa 3
Montreal 3
Mumbai 3
Naples 3
Ninh Bình 3
Paternò 3
Phoenix 3
Salvador 3
Vitória da Conquista 3
Zagreb 3
Aci Catena 2
Addis Ababa 2
Athens 2
Auckland 2
Bari 2
Bengaluru 2
Bologna 2
Campina Grande 2
Can Tho 2
Canoas 2
Casablanca 2
Chengdu 2
Chicago 2
Chiclayo 2
City of London 2
Congonhas 2
Cotia 2
Council Bluffs 2
Delhi 2
El Tigre 2
Florence 2
Florianópolis 2
Fort Lauderdale 2
Ghaziabad 2
Giulianova 2
Goiânia 2
Itanhaém 2
Itaquaquecetuba 2
Jundiaí 2
Kansas City 2
Kuala Lumpur 2
Lagoa Grande 2
Lagoa da Prata 2
Leeds 2
Totale 1.706
Salva come PNG Salva come JPEG
Nome #
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 117
Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis 76
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 68
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 67
Raised Asymmetric Dimethyl Arginine (ADMA) is associated with high Plasma Norepinephrine (NE) in patients with End Stage Renal Disease (ESRD). 66
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 57
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 57
Diagnostic value of troponin-t for alterations in left ventricular mass and function in dialysis patients 54
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 51
Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD). 51
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. 50
Adiponectin, the most abundant adipocyte-derived protein, is functionally related to metabolic risk factors and predicts cardiovascular events in patients with end stage renal disease 49
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 48
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 47
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 46
FGF23 and the PTH response to paricalcitol in chronic kidney disease 46
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 42
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients 42
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients 41
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. 39
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 39
Intact FGF23 and -klotho during acute inflammation/sepsis in CKD patients 37
L'obesità addominale interagisce con due citochine prodotte dal tessuto adiposo, Leptina ed Adiponectina, per predire il rischio di mortalità totale e cardiovascolare nei pazienti in dialisi. 36
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 36
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 36
INDICES OF INSULIN RESISTANCE AND RISK OF TOTAL AND CARDIOVASCULAR MORTALITY IN DIALYSIS PATIENTS 34
Il rischio di progressione delle nefropatie croniche e mortalità: ruolo dell'Asymmetrical Di-Methil-Arginine (ADMA). 33
C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients. 33
Prospective study of Neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease. 31
Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD). 31
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 30
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 30
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortatlity in hemodialysis patients. 30
L'attività simpatica è strettamente correlata ai livelli corcolanti di dimetil arginina asimmetrica (ADMA) nei pazienti in trattamento emodialitico 29
Sympathetic activity and asymmetric dimethyl arginine (ADMA) in patients with end stage renal disease (ESRD). 28
Low triiodothyronine and survival in end-stage renal disease. 28
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 27
Urotensin II and cardiomyopathy in end-stage renal disease. 26
Urotensin II is inversely related to markers of endothelial activation and inflammation and is an inverse predictor of incident cardiovascolar events in end stage renal disease (ESRD). 26
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD 26
Salt intake and inflammation in essential hypertension. 26
Plasma nor-epinephrine predicts survival and incident cardiovascular events in patients with end stage renal disease 26
Vascular endothelial growth factor (VRGF) is a marker of left ventricular dysfunction and predicts mortality in hemodialysis (HD) patients. 26
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease 26
Vitamin D levels and patient outcome in chronic kidney disease. 25
L'iperparatiroidismo e il TNF-a come determinanti dell'incidenza di fratture nei pazienti in dialisi: uno studio di coorte. 25
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease 25
Low triiodothyronine and survival in end stage renal disease (ESRD). 25
Waist circumference modifies the relationship of adipose tissue cytochines leptin and adiponectin with all-cause and cardiovascular mortality in end stage renal disease (ESRD). 25
L'infiammazione amplifica il rischio di mortalità ed eventi cardiovascolari connesso ai livelli circolanti di dimetilarginina asimmetrica (ADMA) nei pazienti in dialisi. 25
Pattern evolutivo dei biomarcatori di infiammazione e dei fattori di rischio non tradizionali dopo trapianto renale. 24
Low Triiodothyronine and Cardiomyopathy in Patients with End-Stage Renal Disease (ESRD). 24
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. 24
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 24
Urotensin II and biomarkers of endothelial activation and atherosclerosis in end stage renal disease (ESRD). 24
Urotensin II partecipates in cardiovascular control in end stage renal disease (ESRD). 23
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 23
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 23
Vascular Endothelial Growth Factor, rimodellamento ventricolare sinistro e disfunzione sistolica nei pazienti in dialisi 23
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 23
Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides 22
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 22
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients. 22
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in CKD patients. 22
L'ipotiroidismo subclinico si associa alla micro-infiammazione cronica e predice la mortalità nei pazienti in CAPD. Risultati di uno studio pilota di coorte. 22
Salivary and lacrimal secretion is reduced in patients with ESRD. 22
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 21
Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease 20
La concentrazione plasmatica di Neuropeptide Y è correlata ai livelli circolanti di Noradrenalina e predice l'incidenza di eventi cardiovascolari (CV) nei pazienti in dialisi. 20
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease. 20
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 20
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 20
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. 20
Valore diagnostico per il basso turnover osseo del PTH dosato con metodi RIA di prima e seconda generazione. 20
Neuropeptide Y (NPY), norepinephrine and incident cardiovascular events in and-tage renal disease (ESRD). 19
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients. 19
Norepinephrine and concentric hypertrophy in patients with end stage renal disease. 19
Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study 19
La riduzione dell intake di sale influenza l infiammazione nell ipertensione arteriosa essenziale? 19
Urotensina II e fattori di rischio cardiovascolare nei pazienti con insufficienza renale cronica in trattamento dialitico. 18
Smoking and hyperparathyroidism in patients with end stage renal disease (ESRD). 18
Livelli circolanti di tiiodrotironina (fT3) e mortalità nei pazienti in dialisi. 18
Thyroid sick syndrome e miocardiopatia nei pazienti con insufficienza renale cronica. 17
Which is the best inflammation marker? A comparative study based on multivariate modelling of mortality in end stage renal disease (ESRD) patients. 17
Diagnostic value for low bone turnover of first and second generation immuno-radiometric PTH assay. 17
Low Triiodothyronine (fT3): a new facet of inflammation in end stage renale disease (ESRD). 17
Vascular endothelial growth factor, left ventricular remodeling and systolic dysfunction in end stage renal disease 17
I predittori degli eventi cardiovascolari nei pazienti in dialisi. 17
Does sub-clinical hypothyroidism predict survival in patients on Continuous Ambulatory Peritoneal Dialysis? 17
Il fumo amplifica il rischio di iperparatiroidismo secondario nei pazienti in dialisi. 16
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections 16
Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis 15
Vascular Endothelial Growth Factor, Inflammation, Cardiomyopathy and Mortality in End-Stage-Renal Disease (ESRD) 14
Asymmetrical Di-Methyl-Arginine (ADMA) predicts progression to dialysis and death in patients with chronic kidney disease (CKD). 13
Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease 13
Totale 2.917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.026
article - articoli 5.501
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202427 0 0 0 0 0 0 0 0 24 0 3 0
2024/20251.143 5 9 94 77 258 11 13 53 24 39 290 270
2025/20261.747 70 162 175 249 321 54 275 135 77 102 123 4
Totale 2.917